Oasmia förtydligar artikel

En amerikansk analystjänst uppgav att Oasmia för långt gångna diskussioner om utlicensiering. Nu förtydligar bolaget.

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Addlife ökar försäljningen

Säljer mer men ebita-marginalen minskar på grund av bolagets förvärv inom medtech.

Tillväxten fortsätter för Vitrolife

Bioteknikföretaget Vitrolife redovisade en ökad försäljning på 129 miljoner kr för årets andra kvartal, att jämföra med 116 miljoner kr för motsvarande period f...

Swedish life science in political focus

It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Krönika: Collaboration across borders

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Ny generation digitala mikroskop med många applikationer

DVM2500 och DVM5000 HD är namnen på två nya mikroskopsystem som ska kunna skräddarsys för att passa en lång rad olika applikationer.

Stark ökning för Vitrolife

Visar upp en kraftigt ökad försäljning av sina fertilitetsprodukter och väntar sig ytterligare positiv utveckling av marknaden.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Oslo Cancer Cluster

Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...

Hallå där Sarah Fredriksson...

... vd på labbteknikföretaget Genovis i Lund, som ska tala på Life Science Management Day. Vad ska du prata om?

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

LEO Pharma - International Clinical Trial Manager

Två tillvägagångssätt i ett MS-system

Lucid proteomics systemO är en masspektrometer som kan användas i både top-down- och bottom-up-proteomik.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.